These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

514 related articles for article (PubMed ID: 33177247)

  • 1. Prognostic risk signature based on the expression of three m6A RNA methylation regulatory genes in kidney renal papillary cell carcinoma.
    Sun Z; Jing C; Xiao C; Li T; Wang Y
    Aging (Albany NY); 2020 Nov; 12(21):22078-22094. PubMed ID: 33177247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a Two-m6A RNA Methylation Regulator Risk Signature as an Independent Prognostic Biomarker in Papillary Renal Cell Carcinoma by Bioinformatic Analysis.
    Yang F; Zhao G; Ge L; Song Y; Hong K; Zhang H; Liu C; Hong P; Ma L
    Biomed Res Int; 2021; 2021():4582082. PubMed ID: 33628782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma.
    Guo W; Tan F; Huai Q; Wang Z; Shao F; Zhang G; Yang Z; Li R; Xue Q; Gao S; He J
    Front Immunol; 2021; 12():669750. PubMed ID: 34054840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioinformatic analyses and experimental validation of the role of m6A RNA methylation regulators in progression and prognosis of adrenocortical carcinoma.
    Xu F; Guan Y; Ma Y; Xue L; Zhang P; Yang X; Chong T
    Aging (Albany NY); 2021 Apr; 13(8):11919-11941. PubMed ID: 33952721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and Validation of an m6A RNA Methylation Regulators-Based Signature for Predicting the Prognosis of Adrenocortical Carcinoma.
    Shen C; Liu J; Yang X; Jiao W; Wang Y
    Front Endocrinol (Lausanne); 2021; 12():568397. PubMed ID: 33692753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction autophagy-related prognostic risk signature combined with clinicopathological validation analysis for survival prediction of kidney renal papillary cell carcinoma patients.
    Fei H; Chen S; Xu C
    BMC Cancer; 2021 Apr; 21(1):411. PubMed ID: 33858375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. m6A RNA methylation regulators correlate with malignant progression and have potential predictive values in clear cell renal cell carcinoma.
    Zhang QJ; Luan JC; Song LB; Cong R; Ji CJ; Zhou X; Xia JD; Song NH
    Exp Cell Res; 2020 Jul; 392(1):112015. PubMed ID: 32333907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N6‑methyladenosine RNA methylation regulators participate in malignant progression and have prognostic value in clear cell renal cell carcinoma.
    Zheng Z; Mao S; Guo Y; Zhang W; Liu J; Li C; Yao X
    Oncol Rep; 2020 May; 43(5):1591-1605. PubMed ID: 32323803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. m
    Hou J; Shan H; Zhang Y; Fan Y; Wu B
    Am J Otolaryngol; 2020; 41(4):102547. PubMed ID: 32474328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive Analysis of N6-Methyladenosine-Related IncRNAs Prognostic Signature and the Associated Immune Infiltrates in Kidney Renal Clear Cell Carcinoma.
    Chen X; Wang L; Tu J; Pan X; Li Y; Yin H; Wang M; Yuan X
    Crit Rev Eukaryot Gene Expr; 2022; 32(1):79-98. PubMed ID: 35377983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Prognostic Value of m6A RNA Methylation Regulators in Colon Adenocarcinoma.
    Liu T; Li C; Jin L; Li C; Wang L
    Med Sci Monit; 2019 Dec; 25():9435-9445. PubMed ID: 31823961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction and validation of an autophagy-related long non-coding RNA signature to predict the prognosis of kidney renal papillary cell carcinoma.
    Kang Z; Yang J
    J Investig Med; 2022 Oct; 70(7):1536-1544. PubMed ID: 35725019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. M6A-related bioinformatics analysis reveals that HNRNPC facilitates progression of OSCC via EMT.
    Huang GZ; Wu QQ; Zheng ZN; Shao TR; Chen YC; Zeng WS; Lv XZ
    Aging (Albany NY); 2020 Jun; 12(12):11667-11684. PubMed ID: 32526707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. cg04448376, cg24387542, cg08548498, and cg14621323 as a Novel Signature to Predict Prognosis in Kidney Renal Papillary Cell Carcinoma.
    Wang YL; Zhang YY
    Biomed Res Int; 2020; 2020():4854390. PubMed ID: 33381555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of prognostic stemness-related genes in kidney renal papillary cell carcinoma.
    Liu Y; Yao Y; Zhang Y; Xu C; Yang T; Qu M; Lu B; Song X; Pan X; Zhou W; Cui X
    BMC Med Genomics; 2024 May; 17(1):121. PubMed ID: 38702698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The significance of m6A RNA methylation regulators in predicting the prognosis and clinical course of HBV-related hepatocellular carcinoma.
    Fang Q; Chen H
    Mol Med; 2020 Jun; 26(1):60. PubMed ID: 32552682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune signature of T follicular helper cells predicts clinical prognostic and therapeutic impact in lung squamous cell carcinoma.
    Xu F; Zhang H; Chen J; Lin L; Chen Y
    Int Immunopharmacol; 2020 Apr; 81():105932. PubMed ID: 31836430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deciphering N
    Zhu J; Wang M; Hu D
    Biomed Res Int; 2020; 2020():2514230. PubMed ID: 32258108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction of immune-related risk signature for renal papillary cell carcinoma.
    Wang Z; Song Q; Yang Z; Chen J; Shang J; Ju W
    Cancer Med; 2019 Jan; 8(1):289-304. PubMed ID: 30516029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression patterns and prognostic value of m6A RNA methylation regulators in adrenocortical carcinoma.
    Fu Y; Sun S; Bi J; Kong C; Yin L
    Medicine (Baltimore); 2021 Mar; 100(10):e25031. PubMed ID: 33725886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.